OTCPK:PHBBF (Hong Kong)
Â
Ordinary Shares - Class H
$
1.93
0 (0%)
11:08 PM EST
Business Description
Pharmaron Beijing Co Ltd
ISIN : CNE100003PG4
Share Class Description:
PHBBF: Ordinary Shares - Class HCompare
Compare
Traded in other countries / regions
300759.China03759.Hong KongPHBBF.USA17Q1.Germany IPO Date
2021-05-28Description
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.63 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.65 | |||||
Debt-to-EBITDA | 4.38 | |||||
Interest Coverage | 8.33 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 2.79 | |||||
Beneish M-Score | -2.74 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 31.2 | |||||
3-Year EBITDA Growth Rate | 19.9 | |||||
3-Year EPS without NRI Growth Rate | 23.9 | |||||
3-Year Book Growth Rate | 12.3 | |||||
Future 3-5Y EPS without NRI Growth Rate | 15.1 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
6-1 Month Momentum % | -14.22 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.52 | |||||
Quick Ratio | 2.23 | |||||
Cash Ratio | 1.39 | |||||
Days Inventory | 50.78 | |||||
Days Sales Outstanding | 68.36 | |||||
Days Payable | 19.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.46 | |||||
Dividend Payout Ratio | 0.33 | |||||
3-Year Dividend Growth Rate | 64.8 | |||||
Forward Dividend Yield % | 1.46 | |||||
5-Year Yield-on-Cost % | 1.46 | |||||
Shareholder Yield % | -4.6 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 35.02 | |||||
Operating Margin % | 14.95 | |||||
Net Margin % | 12.92 | |||||
FCF Margin % | 3.4 | |||||
ROE % | 12.43 | |||||
ROA % | 6.31 | |||||
ROIC % | 8.5 | |||||
ROC (Joel Greenblatt) % | 18.37 | |||||
ROCE % | 9.57 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 22.22 | |||||
PE Ratio without NRI | 20.81 | |||||
Shiller PE Ratio | 35.79 | |||||
PEG Ratio | 0.8 | |||||
PS Ratio | 2.87 | |||||
PB Ratio | 2.62 | |||||
Price-to-Tangible-Book | 3.64 | |||||
Price-to-Free-Cash-Flow | 84.84 | |||||
Price-to-Operating-Cash-Flow | 11.12 | |||||
EV-to-EBIT | 17.51 | |||||
EV-to-EBITDA | 17.51 | |||||
EV-to-Revenue | 2.88 | |||||
EV-to-FCF | 84.69 | |||||
Price-to-Projected-FCF | 3.27 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.83 | |||||
Price-to-Graham-Number | 1.84 | |||||
Earnings Yield (Greenblatt) % | 5.71 | |||||
FCF Yield % | 1.3 | |||||
Forward Rate of Return (Yacktman) % | 19.96 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:PHBBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmaron Beijing Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,595.235 | ||
EPS (TTM) ($) | 0.115 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0.001982 | ||
20-Day SMA ($) | 1.93 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 1.93 - 2.25 | ||
Shares Outstanding (Mil) | 1,787.39 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmaron Beijing Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmaron Beijing Co Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Pharmaron Beijing Co Ltd Frequently Asked Questions
What is Pharmaron Beijing Co Ltd(PHBBF)'s stock price today?
The current price of PHBBF is $1.93. The 52 week high of PHBBF is $2.25 and 52 week low is $1.93.
When is next earnings date of Pharmaron Beijing Co Ltd(PHBBF)?
The next earnings date of Pharmaron Beijing Co Ltd(PHBBF) is 2024-08-28 Est..
Does Pharmaron Beijing Co Ltd(PHBBF) pay dividends? If so, how much?
The Dividend Yield %  of Pharmaron Beijing Co Ltd(PHBBF) is 1.46% (As of Today), Highest Dividend Payout Ratio of Pharmaron Beijing Co Ltd(PHBBF) was 0.38. The lowest was 0.14. And the median was 0.18. The  Forward Dividend Yield % of Pharmaron Beijing Co Ltd(PHBBF) is 1.46%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |